Clinical Trials for Atopic Dermatitis

Find clinical trials for atopic dermatitis. Discover research opportunities and treatment options in your area.

188 Active Trials Found

Showing 188 trials on this page

Page 1 of 10

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

NCT ID: NCT06389136

This clinical trial is studying a medication called upadacitinib for adults with moderate to severe atopic dermatitis (AD), a skin condition that causes rashes and itching. The trial aims to find o...

Recruiting

Phase: PHASE3 Type: interventional Locations: Doral, Florida, United States, Dawsonville, Georgia, United States +98 more

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

NCT ID: NCT06461897

This clinical trial is studying two treatments for children aged 2 to less than 12 years who have moderate to severe atopic dermatitis (AD), a skin condition that causes rashes and itching. The tri...

Recruiting

Phase: PHASE3 Type: interventional Locations: Savannah, Georgia, United States, Boise, Idaho, United States +132 more

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

NCT ID: NCT07003425

This clinical trial is studying a medication called APG777 to see how safe and effective it is for people with moderate-to-severe atopic dermatitis (AD), a condition that causes itchy and inflamed ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Coral Gables, Florida, United States, Fountain Valley, California, United States +32 more

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT07011706

This clinical trial is studying a new medication called ATI-045 to see how well it works compared to a placebo (a non-active treatment) for people with moderate-to-severe atopic dermatitis, which i...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bryant, Arkansas, United States, Encinitas, California, United States +16 more

Natural History and Genetics of Food Allergy and Related Conditions

NCT ID: NCT02504853

This clinical trial is studying food allergies and related conditions, such as Loeys-Dietz Syndrome, Atopic Dermatitis, and Eosinophilic Esophagitis. Researchers aim to understand more about what c...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT ID: NCT06058156

This clinical trial is studying a new treatment called SAR444656 for adults with moderate to severe atopic dermatitis (AD), a chronic skin condition that causes itchy and inflamed skin. The trial a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hollywood, Florida, United States, Weston, Florida, United States +60 more

A Study Evaluating APG777 in Atopic Dermatitis

NCT ID: NCT06395948

This clinical trial is looking at a new treatment called APG777 for people with moderate-to-severe Atopic Dermatitis (AD), which is a skin condition that causes itchy and inflamed skin. The study i...

Recruiting

Phase: PHASE2 Type: interventional Locations: Coral Gables, Florida, United States, Coral Gables, Florida, United States +84 more

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT ID: NCT06832618

This clinical trial is looking at a new cream called ruxolitinib to see if it is effective and safe for children and teenagers aged 6 to under 18 who have moderate atopic dermatitis, which is a typ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Milwaukee, Wisconsin, United States, Rochester, New York, United States +91 more

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT ID: NCT06947993

This clinical trial is looking at new treatments for people with moderate to severe atopic dermatitis, which is a chronic skin condition that causes itchy and inflamed skin. The trial aims to test ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Atlanta, Georgia, United States, Saint Joseph, Missouri, United States +9 more

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT07027527

This clinical trial is studying the safety and how the body processes a new combination of medicines called APG777 and APG990 for adults with moderate-to-severe atopic dermatitis, a common skin con...

Recruiting

Phase: PHASE1 Type: interventional Locations: Carlton, Victoria, Australia

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT ID: NCT06807281

This clinical trial is studying a medicine called abrocitinib, which is a liquid treatment for children aged 2 years and older who have moderate to severe eczema, also known as atopic dermatitis. T...

Not yet recruiting

Phase: PHASE3 Type: interventional

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

NCT ID: NCT05721937

This clinical trial is studying the safety of a medication called abrocitinib (CIBINQO) for pregnant women who have a skin condition known as moderate-to-severe atopic dermatitis. The researchers w...

Recruiting

Type: observational Locations: New York, New York, United States, New York, New York, United States

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

NCT ID: NCT05689151

This clinical trial is looking at a medication called Abrocitinib to see how safe and effective it is for adults with moderate to severe atopic dermatitis, also known as eczema. Atopic dermatitis i...

Recruiting

Type: observational Locations: Paris, , France, Dijon, , France +10 more

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

NCT ID: NCT06899204

This clinical trial is studying the use of a medication called abrocitinib for patients with moderate to severe atopic dermatitis, a skin condition that causes itchy and inflamed skin. The trial ai...

Not yet recruiting

Type: observational

A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

NCT ID: NCT05387980

This clinical trial is studying a medication called CIBINQO to see how safe and effective it is for treating atopic dermatitis, a skin condition that causes itchy and inflamed skin. The trial is cu...

Recruiting

Type: observational Locations: Tokyo, , Japan

National Register of Moderate and Severe Adult Atopic Dermatitis

NCT ID: NCT06313333

This clinical trial is focused on gathering information about adults with moderate to severe atopic dermatitis, which is a chronic skin condition that causes itchy and inflamed skin. The researcher...

Recruiting

Type: observational Locations: Brescia, , Italy

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

NCT ID: NCT06988605

This clinical trial is studying the effectiveness of a medication called nemolizumab (brand name: Nemluvio®) for treating moderate-to-severe atopic dermatitis, a chronic skin condition that causes ...

Not yet recruiting

Type: observational

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

NCT ID: NCT00605878

This clinical trial is investigating the tiny living organisms, like bacteria and fungi, that naturally exist on our skin and how they might affect our health, especially in people with skin condit...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT ID: NCT06342713

This clinical trial is studying a new drug called BGB-45035 to see how safe it is and how the body processes it. This is the first time BGB-45035 is being given to people, so researchers want to fi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shenyang, Liaoning, China, Chengdu, Sichuan, China +14 more

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Atopic Dermatitis

NCT ID: NCT06863961

This clinical trial is studying a new treatment called RO7790121 for people with moderate to severe atopic dermatitis, which is a skin condition that causes itchy and inflamed skin. The goal of the...

Recruiting

Phase: PHASE2 Type: interventional Locations: Dallas, Texas, United States, Arlington, Texas, United States +12 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions